Search

Search Constraints

You searched for: Author/Creator Riganti, Chiara

Search Results

1. 6, 7-Dimethoxy-2-phenethyl-1, 2, 3, 4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers. (1st January 2020)

2. A harmonized protocol for an international multicenter prospective study of nanotechnology workers: the NanoExplore cohort. Issue 1 (2nd January 2023)

4. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. Issue 1 (December 2017)

5. An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo. Issue 8 (10th August 2018)

6. Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies. (5th June 2015)

7. Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. (4th March 2018)

9. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Issue 1 (9th March 2020)

10. Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]. (March 2023)